Pheochromocytoma and bowel ischemia.

A. Salehi,E. Legome,K. Eichhorn,R. Jacobs

DOI: https://doi.org/10.1016/S0736-4679(96)00241-7

IF: 1.473

Journal of Emergency Medicine

Abstract:

What problem does this paper attempt to address?

Post-stroke rehabilitation in the peri-pandemic COVID-19 era

Meirgul I. Assylbek,Burhan Fatih Kocyigit,Marlen Yessirkepov,Olena Zimba

DOI: https://doi.org/10.1007/s00296-023-05520-1

2024-02-16

Rheumatology International

Abstract:The coronavirus disease 2019 (COVID-19), which arose in late 2019, caused extensive destruction, impacting a substantial proportion of the worldwide population and leading to millions of deaths. Although COVID-19 is mainly linked to respiratory and pulmonary complications, it has the potential to affect neurologic structures as well. Neurological involvement may manifest as minimal and reversible; however, a notable proportion of cases have exhibited pronounced neurological consequences, such as strokes. Endothelial inflammation, hypercoagulation, renin–angiotensin–aldosterone system alterations, and cardiogenic embolism are the pathophysiological mechanisms of stroke under COVID-19 circumstances. Physical activity and exercise have improved several aspects of post-stroke recovery, including cardiovascular health, walking capacity, and upper limb strength. They are commonly used to assist stroke survivors in overcoming their motor restrictions. Furthermore, stroke rehabilitation can incorporate a range of specific techniques, including body-weight-supported treadmill applications, constraint-induced movement therapy, robotic rehabilitation interventions, transcranial direct current stimulation, transcranial magnetic stimulation, and prism adaptation training. Under pandemic conditions, there were several barriers to neurological rehabilitation. The most significant of these were individual's fear of infection, which caused them to postpone their rehabilitation applications and rehabilitation areas being converted into COVID-19 units. The primary emphasis had turned to COVID-19 treatment. Several valuable data and views were gained in reorganizing rehabilitation during the pandemic, contributing to establishing future views in this regard.

rheumatology
On Weighting of Data Matrix in Subspace Identification

Y. Takei,H. Nanto,S. Kanae,Zi‐Jiang Yang,K. Wada

DOI: https://doi.org/10.1109/CDC.2007.4435002

2007-12-01

Abstract:The MOESP types of the subspace algorithms which are originally proposed by Verhaegen are considered at the point of view from the weighting of the data matrices. We have proposed an interpretation of these types of subspace algorithms by using the Schur complement (SC) of the data product moment and derive a unified framework for the subspace-based identification. This paper shows the proposed unified approach for the subspace identification will be reviewed at the point of view from the results of the Subspace-based identification using instrumental variables (SIV) approach by Gustafsson. Furthermore, we consider the introduction of exponential forgetting factor which windows the data matrices to apply the algorithms to the slowly time-varying system. The data matrix is windowed to reduce the influence of old data, which the forgetting factor or the sliding window can be used. Here it will show that the window weighting can also be reformed as the weighting of the data product moment and the proposed unified framework still kept consequently.
Examining Brain Structures and Cognitive Functions in Patients with Recovered COVID-19 Infection: A Multicenter Study Using 7T MRI

Jr-Jiun Liou,Tales Santini,Jinghang Li,Monica Gireud-Goss,Vibhuti Patel,Oluwatobi Adeyemi,Gabriel A de Erausquin,Valentina Garbarino,Mohamad Habes,Jayandra J Himali,Christof Karmonik,Beth Snitz,Joseph Mettenburg,Minjie Wu,Howard Aizenstein,Anna Marsland,Peter Gianaros,Richard Bowtell,Olivier Mougin,Farhaan S Vahidy,Timothy Girard,Heidi I.L. Jacobs,Akram A. Hosseini,Sudha Seshadri,Tamer S Ibrahim

DOI: https://doi.org/10.1101/2024.11.13.24317121

2024-11-15

Abstract:Importance: Emerging evidence suggests that severe acute respiratory syndrome, COVID-19, negatively impacts brain health, with clinical magnetic resonance imaging (MRI) showing a wide range of neurologic manifestations but no consistent pattern. Compared with 3 Tesla (3T) MRI, 7 Tesla (7T) MRI can detect more subtle injuries, including hippocampal subfield volume differences and additional standard biomarkers such as white matter lesions. 7T MRI could help with the interpretation of the various persistent post-acute and distal onset sequelae of COVID-19 infection. Objective: To investigate the differences in white matter hyperintensity (WMH), hippocampal subfields volumes, and cognition between patients hospitalized with COVID-19 and non-hospitalized participants in a multi-site/multi-national cohort. Design: Original investigation of patients hospitalized with COVID-19 between 5/2020 and 10/2022 in 3 USA and 1 UK medical centers with follow-up at hospital discharge. Participants: A total of 179 participants without a history of dementia completed cognitive, mood and other assessments and MRI scans. Exposure: COVID-19 severity, as measured by hospitalization vs no hospitalization Main Outcomes and Measures: 7T MRI scans were acquired. All WMH and hippocampal subfield volumes were corrected for intracranial volumes to account for subject variability. Cognition was assessed using a comprehensive battery of tests. Pearson correlations and unpaired t-tests were performed to assess correlations and differences between hospitalized and non-hospitalized groups. Results: We found similar WMH volume (4112 vs 3144mm3, p=0.2131), smaller hippocampal volume (11856 vs 12227mm3, p=0.0497) and lower cognitive and memory performance, especially the MoCA score (24.9 vs 26.4 pts, p=0.0084), duration completing trail making test B (97.6 vs 79.4 seconds, p=0.0285), Craft immediate recall (12.6 vs 16.4 pts, p<0.0001) , Craft delay recall (12.0 vs 15.6 pts, p=0.0001), and Benson figure copy (15.2 vs 16.1 pts, p=0.0078) in 52 patients hospitalized for COVID-19 (19[37%] female; mean[SD] age, 61.1[7.4] years) compared with 111 age-matched non-hospitalized participants (66[59%] female; mean[SD] age, 61.5[8.4] years). Conclusions and Relevance: Our results indicate that hospitalized COVID-19 cases show lower hippocampal volume when compared to non-hospitalized participants. We also show that WMH and hippocampal volumes correlate with worse cognitive scores in hospitalized patients compared with non-hospitalized participants, potentially indicating recent lesions and atrophy.

Infectious Diseases (except HIV/AIDS)
Gonorrhea in the female.

M. Parker

Abstract:
Cerebral Micro-Structural Changes in COVID-19 Patients: an MRI-Based Preliminary Study

Yiping Lu,Xuanxuan Li,Daoying Geng,Pu-Yeh Wu,Chu-Chung Huang,Tianye Jia,Nan Mei,Yajing Zhao,Dongdong Wang,Bo Yin,Anling Xiao

DOI: https://doi.org/10.2139/ssrn.3633178

2020-01-01

Abstract:Background: Increasing evidence supported the possible neuro-invasion potential of SARS-CoV-2. However, no studies were conducted to explore the existence of the structural changes in the neurological system after infection. We aimed to identify the existence of potential brain structural changes related to SARS-CoV-2. Methods: In this prospective study, diffusion tensor imaging (DTI) and 3D high-resolution T1WI sequences were acquired in 48 recovered COVID-19 patients (60.42% male; mean age=47.81 ± 19.51) and 31 age-matched healthy controls (29.03% male; age=43.45 ± 13.6). Registered fractional anisotropy (FA), mean (MD), axial (AD), and radial diffusivity (RD) were quantified for DTI, and a brain score system was introduced. Voxel-based Morphometry (VBM) and DTI metrics were compared using ANCOVA. Independent t-test and Spearman correlation were conducted to assess the relationships among imaging indices, brain scores and clinical information. Findings: COVID-19 patients had higher gray matter volumes (GMV) in hippocampus and Heschl's gyrus, and higher white matter volumes (WMV) in corona radiata and tapetum. The left paracentral lobule was found to have significantly lower FA, higher MD, AD and RD values when compared with healthy controls. COVID-19 patients also had lower global MD and RD values, as well as lower brain scores of FA-GM, MD-GM, and MD-WM. MD values in the right corona radiata and external capsule were positively related to LDH level (r = 0.428, 0.417). Interpretation: Study findings reveal possible disruption to micro-structural and functional brain integrity in the recovery stages of COVID-19, suggesting neuro-invasion potential of SARS-CoV-2. Funding: This project was supported by Shanghai Natural Science Foundation (Grant No. 18ZR1405700), Youth Program of National Natural Science Foundation of China (Fund No. 81901697), Shanghai Sailing Program (Grant No. 18YF1403000), Shanghai Science and Technology Development (Fund No. 19511121204), Shanghai Municipal Science and Technology Major Project (No. 2018SHZDZX01) and ZJ Lab.Declaration of Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. Ethics Approval Statement: This was a prospective study, which was approved by the local ethics committee (No.20200616017) and written informed consent was obtained from each participant.
Cerebral Micro-Structural Changes in COVID-19 Patients – an MRI-based 3-Month Follow-up Study

Yiping Lu,Xuanxuan Li,Daoying Geng,Nan Mei,Pu-Yeh Wu,Chu-Chung Huang,Tianye Jia,Yajing Zhao,Dongdong Wang,Anling Xiao,Bo Yin

DOI: https://doi.org/10.1016/j.eclinm.2020.100484

IF: 15.1

2020-01-01

EClinicalMedicine

Abstract:BACKGROUND:Increasing evidence supported the possible neuro-invasion potential of SARS-CoV-2. However, no studies were conducted to explore the existence of the micro-structural changes in the central nervous system after infection. We aimed to identify the existence of potential brain micro-structural changes related to SARS-CoV-2. METHODS:In this prospective study, diffusion tensor imaging (DTI) and 3D high-resolution T1WI sequences were acquired in 60 recovered COVID-19 patients (56.67% male; age: 44.10 ± 16.00) and 39 age- and sex-matched non-COVID-19 controls (56.41% male; age: 45.88 ± 13.90). Registered fractional anisotropy (FA), mean diffusivity (MD), axial diffusivity (AD), and radial diffusivity (RD) were quantified for DTI, and an index score system was introduced. Regional volumes derived from Voxel-based Morphometry (VBM) and DTI metrics were compared using analysis of covariance (ANCOVA). Two sample t-test and Spearman correlation were conducted to assess the relationships among imaging indices, index scores and clinical information. FINDINGS:In this follow-up stage, neurological symptoms were presented in 55% COVID-19 patients. COVID-19 patients had statistically significantly higher bilateral gray matter volumes (GMV) in olfactory cortices, hippocampi, insulas, left Rolandic operculum, left Heschl's gyrus and right cingulate gyrus and a general decline of MD, AD, RD accompanied with an increase of FA in white matter, especially AD in the right CR, EC and SFF, and MD in SFF compared with non-COVID-19 volunteers (corrected p value <0.05). Global GMV, GMVs in left Rolandic operculum, right cingulate, bilateral hippocampi, left Heschl's gyrus, and Global MD of WM were found to correlate with memory loss (p value <0.05). GMVs in the right cingulate gyrus and left hippocampus were related to smell loss (p value <0.05). MD-GM score, global GMV, and GMV in right cingulate gyrus were correlated with LDH level (p value <0.05). INTERPRETATION:Study findings revealed possible disruption to micro-structural and functional brain integrity in the recovery stages of COVID-19, suggesting the long-term consequences of SARS-CoV-2. FUNDING:Shanghai Natural Science Foundation, Youth Program of National Natural Science Foundation of China, Shanghai Sailing Program, Shanghai Science and Technology Development, Shanghai Municipal Science and Technology Major Project and ZJ Lab.
Altered intrinsic brain activity and functional connectivity in COVID-19 hospitalized patients at 6-month follow-up

Ruili Li,Guangxue Liu,Xiaodong Zhang,Miao Zhang,Jie Lu,Hongjun Li

DOI: https://doi.org/10.1186/s12879-023-08331-8

IF: 3.7

2023-01-01

BMC Infectious Diseases

Abstract:Background Although most patients can recover from SARS-CoV-2 infection during the short-term, the long-term effects of COVID-19 on the brain remain explored. Functional MRI (fMRI) could potentially elucidate or otherwise contribute to the investigation of the long COVID syndrome. A lower fMRI response would be translated into decreased brain activity or delayed signal transferring reflecting decreased connectivity. This research aimed to investigate the long-term alterations in the local (regional) brain activity and remote (interregional) functional connection in recovered COVID-19. Methods Thirty-five previously hospitalized COVID-19 patients underwent 3D T 1 weighed imaging and resting-state fMRI at 6-month follow-up, and 36 demographic-matched healthy controls (HCs) were recruited accordingly. The amplitude of low-frequency fluctuation (ALFF) and seed-based functional connectivity (FC) was used to assess the regional intrinsic brain activity and the influence of regional disturbances on FC with other brain regions. Spearman correlation analyses were performed to evaluate the association between brain function changes and clinical variables. Results The incidence of neurosymptoms (6/35, 17.14%) decreased significantly at 6-month follow-up, compared with COVID-19 hospitalization stage (21/35, 60%). Compared with HCs, recovered COVID-19 exhibited higher ALFF in right precuneus, middle temporal gyrus, middle and inferior occipital gyrus, lower ALFF in right middle frontal gyrus and bilateral inferior temporal gyrus. Furthermore, setting seven abnormal activity regions as seeds, we found increased FC between right middle occipital gyrus and left inferior occipital gyrus, and reduced FC between right inferior occipital gyrus and right inferior temporal gyrus/bilateral fusiform gyrus, and between right middle frontal gyrus and right middle frontal gyrus/ supplementary motor cortex/ precuneus. Additionally, abnormal ALFF and FC were associated with clinical variables. Conclusions COVID-19 related neurological symptoms can self heal over time. Recovered COVID-19 presented functional alterations in right frontal, temporal and occipital lobe at 6-month follow-up. Most regional disturbances in ALFF were related to the weakening of short-range regional interactions in the same brain function.
Long-term microstructure and cerebral blood flow changes in patients recovered from COVID-19 without neurological manifestations

Yuanyuan Qin,Jinfeng Wu,Tao Chen,Jia Li,Guiling Zhang,Di Wu,Yiran Zhou,Ning Zheng,Aoling Cai,Qin Ning,Anne Manyande,Fuqiang Xu,Jie Wang,Wenzhen Zhu

DOI: https://doi.org/10.1172/jci147329

IF: 19.456

2021-04-15

Journal of Clinical Investigation

Abstract:BACKGROUND. The coronavirus disease 2019 (COVID-19) rapidly progressed to a global pandemic. Although some patients totally recover from COVID-19 pneumonia, the disease's long-term effects on the brain still need to be explored.METHODS. We recruited 51 patients with 2 subtypes of COVID-19 (19 mild and 32 severe) with no specific neurological manifestations at the acute stage and no obvious lesions on the conventional MRI 3 months after discharge. Changes in gray matter morphometry, cerebral blood flow (CBF), and white matter (WM) microstructure were investigated using MRI. The relationship between brain imaging measurements and inflammation markers was further analyzed.RESULTS. Compared with healthy controls, the decrease in cortical thickness/CBF and the changes in WM microstructure were more severe in patients with severe disease than in those with mild disease, especially in the frontal and limbic systems. Furthermore, changes in brain microstructure, CBF, and tract parameters were significantly correlated (P < 0.05) with the inflammatory markers C-reactive protein, procalcitonin, and interleukin 6.CONCLUSION. Indirect injury related to inflammatory storm may damage the brain, altering cerebral volume, CBF, and WM tracts. COVID-19–related hypoxemia and dysfunction of vascular endothelium may also contribute to neurological changes. The abnormalities in these brain areas need to be monitored during recovery, which could help clinicians understand the potential neurological sequelae of COVID-19.FUNDING. Natural Science Foundation of China.

medicine, research & experimental
Functional brain alterations in COVID-19 patients using resting-state fMRI: a systematic review

Siti Maisarah Nasir,Noorazrul Yahya,Hanani Abdul Manan

DOI: https://doi.org/10.1007/s11682-024-00935-1

2024-10-01

Brain Imaging and Behavior

Abstract:This study systematically reviews the available evidence on resting-state functional magnetic resonance imaging (rs-fMRI) related to neurological symptoms and cognitive declines in COVID-19 patients. We followed PRISMA guidelines and looked up the PubMed, and Scopus databases for articles search on COVID-19 patients with neurological impairments, and functional connectivity alteration using rs-fMRI technique. Articles published between January 1, 2020, and May 31, 2024, are included in this study. The Quality Assessment Tool for Observational Prospective and Cross-Sectional Studies from the National Heart, Lung, and Blood Institute (NHLBI) was used to assess the quality of papers. A total of 15 articles met the inclusion criteria. The result reveals that the most prevalent neurological impairment associated with COVID-19 was cognitive decline, encompassing issues in attention, memory, processing speed, executive functions, language, and visuospatial ability. The brain connectivity results reveal that two brain areas were functionally altered; the prefrontal cortex and parahippocampus. The functional connectivity mainly increased in the frontal, temporal, and anterior piriform cortex, and reduced in the cerebellum, superior orbitofrontal cortex, and middle temporal gyrus, which also correlated with cognitive decline. The findings of neurological symptoms indicate one study reported a Disorder of Consciousness (DoC), and four studies reported COVID-19 patients with olfactory dysfunction. The present study concludes that COVID-19 can alter brain functional connectivity and offers significant insight into how COVID-19 affects the neuronal foundation of cognitive decline and other neurological impairments.

neuroimaging
Altered brain function and structure pre- and post- COVID-19 infection: a longitudinal study

Ping Jin,Feng Cui,Min Xu,Yue Ren,Luping Zhang

DOI: https://doi.org/10.1007/s10072-023-07236-3

2023-12-06

Neurological Sciences

Abstract:Evidence indicates that the SARS-CoV-2 virus can infect the brain, resulting in central nervous system symptoms. However, there is a lack of a longitudinal imaging study investigating the impact of Coronavirus disease 2019 (COVID-19) infection on brain function. Consequently, this study aimed to fill this knowledge gap using functional magnetic resonance imaging (fMRI).

neurosciences,clinical neurology
Tyrosine hydroxylase and parkinsonism.

P. Mcgeer

DOI: https://doi.org/10.1016/S0140-6736(71)92339-7

IF: 202.731

1971-07-17

The Lancet

Abstract:
Brain Abnormalities in Survivors of COVID-19 after 2-Year Recovery: a Functional MRI Study

Yimiao Zhao,Qiongdan Liang,Zhendong Jiang,Huan Mei,Na Zeng,Sizhen Su,Shanshan Wu,Yinghong Ge,Peng Li,Xiao Lin,Kai Yuan,Le Shi,Wei Yan,Xiaoxing Liu,Jie Sun,Weijian Liu,Guido van Wingen,Yujun Gao,Yiqing Tan,Yi Hong,Yu Lu,Ping Wu,Xiujun Zhang,Yongxiang Wang,Jie Shi,Yumei Wang,Lin Lu,Xiangyou Li,Yanping Bao

DOI: https://doi.org/10.1016/j.lanwpc.2024.101086

IF: 8.559

2024-01-01

The Lancet Regional Health - Western Pacific

Abstract:BackgroundA variety of symptoms, particularly cognitive, psychiatric and neurological symptoms, may persist for a long time among individuals recovering from COVID-19. However, the underlying mechanism of these brain abnormalities remains unclear. This study aimed to investigate the long-term neuroimaging effects of COVID-19 infection on brain functional activities using resting-state functional magnetic resonance imaging (rs-fMRI).MethodsFifty-two survivors 27 months after infection (mild-moderate group: 25 participants, severe-critical: 27 participants), from our previous community participants, along with 35 healthy controls, were recruited to undergo fMRI scans and comprehensive cognitive function measurements. Participants were evaluated by subjective assessment of Cognitive Failures Questionnaire-14 (CFQ-14) and Fatigue Scale-14 (FS-14), and objective assessment of Montreal Cognitive Assessment (MoCA), N-back, and Simple Reaction Time (SRT). Each had rs-fMRI at 3T. Measures such as the amplitude of low-frequency fluctuation (ALFF), fractional amplitude of low-frequency fluctuations (fALFF), and regional homogeneity (ReHo) were calculated.FindingsCompared with healthy controls, survivors of mild-moderate acute symptoms group and severe-critical group had a significantly higher score of cognitive complains involving cognitive failure and mental fatigue. However, there was no difference of cognitive complaints between two groups of COVID-19 survivors. The performance of three groups was similar on the score of MoCA, N-back and SRT. The rs-fMRI results showed that COVID-19 survivors exhibited significantly increased ALFF values in the left putamen (PUT.L), right inferior temporal gyrus (ITG.R) and right pallidum (PAL.R), while decreased ALFF values were observed in the right superior parietal gyrus (SPG.R) and left superior temporal gyrus (STG.L). Additionally, decreased ReHo values in the right precentral gyrus (PreCG.R), left postcentral gyrus (PoCG.L), left calcarine fissure and surrounding cortex (CAL.L) and left superior temporal gyrus (STG.L). Furthermore, significant negative correlations between the ReHo values in the STG.L, and CFQ-14 and mental fatigue were found.InterpretationThis long-term study suggests that individuals recovering from COVID-19 continue to experience cognitive complaints, psychiatric and neurological symptoms, and brain functional alteration. The rs-fMRI results indicated that the changes in brain function in regions such as the putamen, temporal lobe, and superior parietal gyrus may contribute to cognitive complaints in individuals with long COVID even after 2-year infection.FundingThe National Programs for Brain Science and Brain-like Intelligence Technology of China, the National Natural Science Foundation of China, Natural Science Foundation of Beijing Municipality of China, and the National Key Research and Development Program of China.
The impact of COVID-19 on home, social, and productivity integration of people with chronic traumatic brain injury or stroke living in the community

Alejandro García-Rudolph,Joan Saurí,Blanca Cegarra,Eloy Opisso,Josep María Tormos,Dietmar Frey,Vince Istvan Madai,Montserrat Bernabeu

DOI: https://doi.org/10.1097/MD.0000000000028695

2022-02-25

Abstract:Compare community integration of people with stroke or traumatic brain injury (TBI) living in the community before and during the coronavirus severe acute respiratory syndrome coronavirus 2 disease (COVID-19) when stratifying by injury: participants with stroke (G1) and with TBI (G2); by functional independence in activities of daily living: independent (G3) and dependent (G4); by age: participants younger than 54 (G5) and older than 54 (G6); and by gender: female (G7) and male (G8) participants.Prospective observational cohort studyIn-person follow-up visits (before COVID-19 outbreak) to a rehabilitation hospital in Spain and on-line during COVID-19.Community dwelling adults (≥18 years) with chronic stroke or TBI.Community integration questionnaire (CIQ) the total-CIQ as well as the subscale domains (ie, home-CIQ, social-CIQ, productivity CIQ) were compared before and during COVID-19 using the Wilcoxon ranked test or paired t test when appropriate reporting Cohen effect sizes (d). The functional independence measure was used to assess functional independence in activities of daily living.Two hundred four participants, 51.4% with stroke and 48.6% with TBI assessed on-line between June 2020 and April 2021 were compared to their own in-person assessments performed before COVID-19.When analyzing total-CIQ, G1 (d = -0.231), G2 (d = -0.240), G3 (d = -0.285), G5 (d = -0.276), G6 (d = -0.199), G7 (d = -0.245), and G8 (d = -0.210) significantly decreased their scores during COVID-19, meanwhile G4 was the only group with no significant differences before and during COVID-19.In productivity-CIQ, G1 (d = -0.197), G4 (d = -0.215), G6 (d = -0.300), and G8 (d = -0.210) significantly increased their scores, meanwhile no significant differences were observed in G2, G3, G5, and G7.In social-CIQ, all groups significantly decreased their scores: G1 (d = -0.348), G2 (d = -0.372), G3 (d = -0.437), G4 (d = -0.253), G5 (d = -0.394), G6 (d = -0.319), G7 (d = -0.355), and G8 (d = -0.365).In home-CIQ only G6 (d = -0.229) significantly decreased, no significant differences were observed in any of the other groups.The largest effect sizes were observed in total-CIQ for G3, in productivity-CIQ for G6, in social-CIQ for G3 and in home-CIQ for G6 (medium effect sizes).Stratifying participants by injury, functionality, age or gender allowed identifying specific CIQ subtotals where remote support may be provided addressing them.
Intact Brain Network Function in an Unresponsive Patient with COVID-19

David Fischer,Zachary D Threlkeld,Yelena G Bodien,John E Kirsch,Susie Y Huang,Pamela W Schaefer,Otto Rapalino,Leigh R Hochberg,Bruce R Rosen,Brian L Edlow

DOI: https://doi.org/10.1002/ana.25838

Abstract:Many patients with severe coronavirus disease 2019 (COVID-19) remain unresponsive after surviving critical illness. Although several structural brain abnormalities have been described, their impact on brain function and implications for prognosis are unknown. Functional neuroimaging, which has prognostic significance, has yet to be explored in this population. Here we describe a patient with severe COVID-19 who, despite prolonged unresponsiveness and structural brain abnormalities, demonstrated intact functional network connectivity, and weeks later recovered the ability to follow commands. When prognosticating for survivors of severe COVID-19, clinicians should consider that brain networks may remain functionally intact despite structural injury and prolonged unresponsiveness. ANN NEUROL 2020;88:851-854.
Comprehensive MRI assessment reveals subtle brain findings in non-hospitalized post-COVID patients with cognitive impairment

Serena Fineschi,Markus Fahlström,David Fällmar,Sven Haller,Johan Wikström

DOI: https://doi.org/10.3389/fnins.2024.1435218

2024-09-10

Abstract:Background: Impaired cognitive ability is one of the most frequently reported neuropsychiatric symptoms in the post-COVID phase among patients. It is unclear whether this condition is related to structural or functional brain changes. Purpose: In this study, we present a multimodal magnetic resonance imaging study of 36 post-COVID patients and 36 individually matched controls who had a mild form of severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) infection from March 2020 to February 2022. This study aimed to investigate structural and functional brain alterations and their correlation with post-COVID symptoms and neurocognitive functions. Materials and methods: The study protocol comprised an assessment of physical fatigue [Fatigue Severity Scale (FSS)], mental fatigue (Mental Fatigue Scale (MFS)], depression [Montgomery Asberg Depression Rating Scale (MADRS)], anxiety [Hospital Anxiety and Depression Scale (HAD)], post-COVID Symptoms Severity Score, and neurocognitive status [Repeatable Battery for the Assessment of Neuropsychological Status Update (RBANS)]. The magnetic resonance imaging protocol included morphological sequences, arterial spin labeling (ASL) and dynamic susceptibility contrast-enhanced (DSC) perfusion, diffusion tensor imaging (DTI), and resting-state functional magnetic resonance imaging (fMRI) sequences. Using these protocols, the assessments of macrostructural abnormalities, perfusion, gray matter density, white matter integrity, and brain connectivity were performed. Results: Post-COVID patients had higher levels of physical fatigue, mental fatigue, depression, and anxiety than controls and showed cognitive impairment in all the RBANS domains except in Visuospatial/Construction. The subjective mental fatigue correlated with objective impaired cognitive ability in the RBANS test, particularly in the Attention domain. There were no differences between patients and controls regarding macrostructural abnormalities, regional volumes, regional perfusion metrics, gray matter density, or DTI parameters. We observed a significant positive correlation between RBANS Total Scale Index score and gray matter volume in the right superior/middle-temporal gyrus (p < 0.05) and a significant negative correlation between the white matter integrity and post-COVID symptoms (p < 0.05) in the same area. The connectivity differences were observed between patients and controls in a few regions, including the right middle frontal gyrus, an important area of convergence of the dorsal and ventral attention networks. We also noted a positive correlation between post-COVID symptoms and increased connectivity in the right temporoparietal junction, which is part of the ventral attention system. Conclusion: In non-hospitalized subjects with post-COVID, we did not find any structural brain changes or changes in perfusion, compared to controls. However, we noted differences in connectivity within an important area for attention processes, which may be associated with post-COVID brain fog.
Cognitive and brain connectivity trajectories in critically ill COVID-19 patients

Daniela Ramos-Usuga,Antonio Jimenez-Marin,Alberto Cabrera-Zubizarreta,Itziar Benito-Sanchez,Diego Rivera,Endika Martínez-Gutiérrez,Elena Panera,Victoria Boado,Fermín Labayen,Jesus M Cortes,Juan C Arango-Lasprilla,Jesus M. Cortes,Juan C. Arango-Lasprilla

DOI: https://doi.org/10.3233/nre-230216

2024-02-24

Neurorehabilitation

Abstract:BACKGROUND: Multiple Organ failure (MOF) is one of the main causes of admission to the Intensive Care Unit (ICU) of patients infected with COVID-19 and can cause short- and long-term neurological deficits. OBJECTIVE: To compare the cognitive functioning and functional brain connectivity at 6–12 months after discharge in two groups of individuals with MOF, one due to COVID-19 and the other due to another cause (MOF-group), with a group of Healthy Controls (HC). METHODS: Thirty-six participants, 12 from each group, underwent a neuropsychological and neuroimaging assessment at both time-points. Functional connectivity of the resting state networks was compared between COVID-19 and HC while controlling for the effect of MOF. The association between functional connectivity and neuropsychological performance was also investigated. RESULTS: Compared to the HC, COVID-19 group demonstrated hypoconnectivity between the Default Mode Network and Salience Network. This pattern was associated with worse performance on tests of attention and information processing speed, at both time-points. CONCLUSION: The study of the association between cognitive function and brain functional connectivity in COVID-19 allows the understanding of the short- and long-term neurological alterations of this disease and promotes the development of intervention programs to improve the quality of life for this understudied population.

clinical neurology,rehabilitation
Post-Stroke Cognitive Impairment: Pathophysiological Insights into Brain Disconnectome from Advanced Neuroimaging Analysis Techniques

Jae-Sung Lim,Jae-Joong Lee,Choong-Wan Woo

DOI: https://doi.org/10.5853/jos.2021.02376

2021-09-30

Journal of Stroke

Abstract:The neurological symptoms of stroke have traditionally provided the foundation for functional mapping of the brain. However, there are many unresolved aspects in our understanding of cerebral activity, especially regarding high-level cognitive functions. This review provides a comprehensive look at the pathophysiology of post-stroke cognitive impairment in light of recent findings from advanced imaging techniques. Combining network neuroscience and clinical neurology, our research focuses on how changes in brain networks correlate with post-stroke cognitive prognosis. More specifically, we first discuss the general consequences of stroke lesions due to damage of canonical resting-state large-scale networks or changes in the composition of the entire brain. We also review emerging methods, such as lesion-network mapping and gradient analysis, used to study the aforementioned events caused by stroke lesions. Lastly, we examine other patient vulnerabilities, such as superimposed amyloid pathology and blood-brain barrier leakage, which potentially lead to different outcomes for the brain network compositions even in the presence of similar stroke lesions. This knowledge will allow a better understanding of the pathophysiology of post-stroke cognitive impairment and provide a theoretical basis for the development of new treatments, such as neuromodulation.

peripheral vascular disease,clinical neurology
Risk of ischemic stroke in patients recovered from COVID-19 infection: A systematic review and meta-analysis

Marco Zuin,Maria Mazzitelli,Gianluca Rigatelli,Claudio Bilato,Anna Maria Cattelan

DOI: https://doi.org/10.1177/23969873231190432

IF: 6.1

2023-07-28

European Stroke Journal

Abstract:European Stroke Journal, Ahead of Print. Background:Data regarding the risk of ischemic stroke within 1 year after the post-acute phase of COVID-19 remain scant. We assess the risk of ischemic stroke in COVID-19 survivors after SARS-CoV-2 infection by performing a systematic review and meta-analysis of the available data.Methods:Following the PRISMA guidelines, we searched Medline and Scopus to locate all articles published up to February 11, 2023, reporting the risk of incident ischemic stroke in adult patients recovered from COVID-19 infection compared to non-infected patients (controls) defined as those who did not experience the infection over the same follow-up period. Ischemic stroke risk was evaluated using the Mantel–Haenszel random effects models with adjusted Hazard ratio (HR) as the effect measure with 95% confidence interval (CI) while heterogeneity was assessed using Higgins I2 statistic.Results:Overall, 23,559,428 patients (mean age 56, 1 year, 54.3% males), of whom 1,595,984 had COVID-19, were included. Over a mean follow-up of 9.2 months, ischemic stroke occurred in 4.40 [95% CI: 4.36–4.43] out of 1000 patients survived to COVID-19 compared to 3.25 [95% CI:3.21–3.29] out of 1000 controls. Recovered COVID-19 patients presented a higher risk of ischemic stroke ((HR: 2.06, 95% CI: 1.75–2.41, p < 0.0001, I2 = 63.7%) compared to people who did not have COVID-19. COVID-19 patients hospitalized at the time of the infection have a subsequent higher risk of stroke during the follow-up compared to those non-hospitalized.Conclusions:Recovered COVID-19 patients have a higher risk of ischemic stroke compared to subjects from the general population within 9 months from the index infection.
The clinical characteristics and prognosis of COVID‐19 patients with cerebral stroke: A retrospective study of 113 cases from one single‐centre

Xiaolong Yao,Shengwen Liu,Junwen Wang,Kai Zhao,Xiaobing Long,Xuejun He,Huicong Kang,Yiping Yang,Xiaopeng Ma,Pengjie Yue,Kai Shu,Zhouping Tang,Ting Lei,Jihong Liu,Wei Wang,Huaqiu Zhang

DOI: https://doi.org/10.1111/ejn.15007

IF: 3.698

2020-12-21

European Journal of Neuroscience

Abstract:To explore the clinical characteristics and prognosis of COVID‐19 patients with cerebral stroke. A total of 2474 COVID‐19 patients from February 10th to March 24th, 2020 were admitted and treated in two branches (Optic Valley and Sino‐French New City branch) of the Tongji Hospital. Data on the clinical characteristics, laboratory parameters and prognosis of COVID‐19 patients with or without cerebral stroke were collected and comparatively analysed. Of the 2474 COVID‐19 patients, 113 (4.7%) patients had cerebral stroke, and 25 (1.0%) patients had new‐onset stroke. Eighty‐eight (77.9%) patients in the previous‐stroke group had cerebral ischaemia, while 25 (22.1%) patients in the new‐onset stroke group had cerebral ischaemia. Most COVID‐19 patients with stroke were elderly with more comorbidities, such as hypertension, diabetes and heart diseases than patients without stroke. Laboratory examinations showed hypercoagulation and elevated serum parameters such as IL‐6, cTnI, NT pro‐BNP and BUN. Consciousness disorders, a long disease course and poor prognosis were also more commonly observed in stroke patients. The mortality rate of stroke patients was almost double (12.4% vs 6.9%) that of patients without stroke. In addition, age, male sex and hypertension were independent predictors for new cerebral stroke in COVID‐19 patients. In conclusion, the high risk of new‐onset stroke must be taken into consideration when treating COVID‐19 patients with an elderly age combined with a history of hypertension. These patients are more vulnerable to multiorgan dysfunction and an overactivated inflammatory response, in turn leading to an unfavourable outcome and higher mortality rate.

neurosciences
Clinical characteristics and treatment outcome of COVID-19 patients with stroke in China: A multicenter retrospective study

Xin-Yu Ji,Yan Ma,Nan-Nan Shi,Ning Liang,Ren-Bo Chen,Si-Hong Liu,Shuai Shi,Gui-Hui Wu,Ji-Ke Li,Hong Chen,Jing-Wei Wang,Hui Na,Ying-Chun Zhou,Min-Qing Li,Yu-Dong Wang,Xiao-Mei Hu,Yun-Hong Hu,Zhang Liu,Hai-Jun Xie,Lin-Song Zhang,Hua-Min Zhang,Yan-Ping Wang,Yong-Yan Wang,Xin-yu Ji,Nan-nan Shi,Ren-bo Chen,Si-hong Liu,Gui-hui Wu,Ji-ke Li,Jing-wei Wang,Ying-chun Zhou,Min-qing Li,Yu-dong Wang,Xiao-mei Hu,Yun-hong Hu,Hai-jun Xie,Lin-song Zhang,Hua-min Zhang,Yan-ping Wang,Yong-yan Wang

DOI: https://doi.org/10.1016/j.phymed.2020.153433

IF: 6.656

2021-01-01

Phytomedicine

Abstract:OBJECTIVE: Previous studies mainly reported the clinical characteristics of novel coronavirus 2019 (COVID-19) infections, but the research on clinical characteristics and treatment outcomes of COVID-19 patients with stroke is still rare.METHODS: A multi-center retrospective study was conducted at 11 hospitals in 4 provinces of China, and COVID-19 patients with stroke were enrolled from February 24 to May 4, 2020. We analyzed epidemiological, demographic, and clinical characteristics of cases as well as the laboratory test results, treatment regimens and outcomes, and the clinical characteristics and therapeutic outcomes were compared between severe and nonsevere patients, and by age group, respectively.RESULTS: A total of 27 patients [mean age: 66.41 (SD 12.1) years] were enrolled. Among them, 9 (33.3%) were severe patients and 18 (66.7%) were nonsevere patients; 17 (63.0%) were female; 19 (70.4%) were aged 60 years and above. The most common symptoms were fever [19 (70.4%)], fatigue [12 (44.4%)] and cough [11 (40.7%)], respectively. Abnormal laboratory findings of COVID-19 patients with stroke included high levels of C-reactive protein [19 (73.1%)], D-dimer [14 (58.3%)], blood glucose [14 (53.8%)], fibrinogen [13 (50.0%)], and decreased lymphocytes [12 (44.4%)]. Comparing to nonsevere cases with stroke, severe patients with stroke were likely to be older, susceptible to receiving oxygen inhalation, and had more complications (p < 0.05). In addition, there were significant differences in lymphocytes, neutrophils, lactate dehydrogenase, C-reactive protein, creatine kinase between the severe cases and nonsevere cases (p < 0.05). The older patients had a decreased platelet count and elevated fibrinogen, compared with the younger (p < 0.05). All patients (100%) received antiviral treatment, 12 (44.4%) received antibiotics treatment, 26 (96.3%) received Traditional Chinese Medicine (Lung cleansing & detoxifying decoction), and oxygen inhalation was in 18 (66.7%). The median duration of hospitalization was 16 days. By May 4, 2020, a total of 26 (96.3%) patients were cured and discharged, and 1 (3.7%) patients died.CONCLUSION: COVID-19 patients with stroke had poor indicators of coagulation system, and severe and older patients might have a higher risk of complications and unfavorable coagulation system. However, the overall treatment outcome is favorable.

pharmacology & pharmacy,chemistry, medicinal,integrative & complementary medicine,plant sciences

Pheochromocytoma and bowel ischemia.

Post-stroke rehabilitation in the peri-pandemic COVID-19 era

On Weighting of Data Matrix in Subspace Identification

Examining Brain Structures and Cognitive Functions in Patients with Recovered COVID-19 Infection: A Multicenter Study Using 7T MRI

Gonorrhea in the female.

Cerebral Micro-Structural Changes in COVID-19 Patients: an MRI-Based Preliminary Study

Cerebral Micro-Structural Changes in COVID-19 Patients – an MRI-based 3-Month Follow-up Study

Altered intrinsic brain activity and functional connectivity in COVID-19 hospitalized patients at 6-month follow-up

Long-term microstructure and cerebral blood flow changes in patients recovered from COVID-19 without neurological manifestations

Functional brain alterations in COVID-19 patients using resting-state fMRI: a systematic review

Altered brain function and structure pre- and post- COVID-19 infection: a longitudinal study

Tyrosine hydroxylase and parkinsonism.

Brain Abnormalities in Survivors of COVID-19 after 2-Year Recovery: a Functional MRI Study

The impact of COVID-19 on home, social, and productivity integration of people with chronic traumatic brain injury or stroke living in the community

Intact Brain Network Function in an Unresponsive Patient with COVID-19

Comprehensive MRI assessment reveals subtle brain findings in non-hospitalized post-COVID patients with cognitive impairment

Cognitive and brain connectivity trajectories in critically ill COVID-19 patients

Post-Stroke Cognitive Impairment: Pathophysiological Insights into Brain Disconnectome from Advanced Neuroimaging Analysis Techniques

Risk of ischemic stroke in patients recovered from COVID-19 infection: A systematic review and meta-analysis

The clinical characteristics and prognosis of COVID‐19 patients with cerebral stroke: A retrospective study of 113 cases from one single‐centre

Clinical characteristics and treatment outcome of COVID-19 patients with stroke in China: A multicenter retrospective study